Nitric Oxide Therapy for Dermatologic Disease

References

• Han G , ZippinJH, FriedmanA. From bench to bedside: the therapeutic potential of nitric oxide in dermatology. J. Drugs Dermatol.8(6), 586–594 (2009).
   PubMed Web of Science ®Google Scholar
• Kutner AJ , FriedmanAJ. Use of nitric oxide nanoparticulate platform for the treatment of skin and soft tissue infections. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.5(5), 502–514 (2013).
   PubMed Web of Science ®Google Scholar
• Kuhn A , FehselK, LehmannP, KrutmannJ, RuzickaT, Kolb-BachofenV. Aberrant timing in epidermal expression of inducible nitric oxide synthase after UV irradiation in cutaneous lupus erythematosus. J. Invest. Dermatol.111(1), 149–153 (1998).
   PubMed Web of Science ®Google Scholar
• Ormerod AD , DwyerCM, ReidA, CopelandP, ThompsonWD. Inducible nitric oxide synthase demonstrated in allergic and irritant contact dermatitis. Acta Derm. Venereol.77(6), 436–440 (1997).
   PubMed Web of Science ®Google Scholar
• Ormerod AD , WellerR, CopelandPet al. Detection of nitric oxide and nitric oxide synthases in psoriasis. Arch. Dermatol. Res.290(1–2), 3–8 (1998).
   PubMed Web of Science ®Google Scholar
• Rowe A , FarrellAM, BunkerCB. Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses. Br. J. Dermatol.136(1), 18–23 (1997).
   PubMed Web of Science ®Google Scholar
• Hsu YC , HsiaoM, WangLF, ChienYW, LeeWR. Nitric oxide produced by iNOS is associated with collagen synthesis in keloid scar formation. Nitric Oxide14(4), 327–334 (2006).
   PubMed Web of Science ®Google Scholar
• Dooley A , LowSY, HolmesAet al. Nitric oxide synthase expression and activity in the tight-skin mouse model of fibrosis. Rheumatology (Oxford)47(3), 272–280 (2008).
   PubMed Web of Science ®Google Scholar
• Marquina M , EspanaA, Fernandez-GalarM, Lopez-ZabalzaMJ. The role of nitric oxide synthases in Pemphigus vulgaris in a mouse model. Br. J. Dermatol.159(1), 68–76 (2008).
   PubMed Web of Science ®Google Scholar
• Di Giunta G , Da SilvaAM, SottoMN. Inducible nitric oxide synthase in pityriasis lichenoides lesions. J. Cutan. Pathol.36(3), 325–330 (2009).
   PubMed Web of Science ®Google Scholar
• Tsukazaki N , WatanabeM, ShimizuK, HamasakiY, KatayamaI. Photoprovocation test and immunohistochemical analysis of inducible nitric oxide synthase expression in patients with Sjogren’s syndrome associated with photosensitivity. Br. J. Dermatol.147(6), 1102–1108 (2002).
   PubMed Web of Science ®Google Scholar
• Lerner LH , QureshiAA, ReddyBV, LernerEA. Nitric oxide synthase in toxic epidermal necrolysis and Stevens-Johnson syndrome. J. Invest. Dermatol.114(1), 196–199 (2000).
   PubMed Web of Science ®Google Scholar
• Cals-Grierson MM , OrmerodAD. Nitric oxide function in the skin. Nitric Oxide10(4), 179–193 (2004).
   PubMed Web of Science ®Google Scholar
• Pautz A , ArtJ, HahnS, NowagS, VossC, KleinertH. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide23(2), 75–93 (2010).
   PubMed Web of Science ®Google Scholar
• Wimalawansa SJ . Nitric oxide: new evidence for novel therapeutic indications. Expert Opin. Pharmacother.9(11), 1935–1954 (2008).
   PubMed Web of Science ®Google Scholar
• Ormerod AD , CopelandP, ShahSA. Treatment of psoriasis with topical NG-monomethyl-L-arginine, an inhibitor of nitric oxide synthesis. Br. J. Dermatol.142(5), 985–990 (2000).
   PubMed Web of Science ®Google Scholar
• Flavahan NA , VanhouttePM. Endothelial cell signaling and endothelial dysfunction. Am. J. Hypertens.8(5 Pt 2), S28–S41 (1995).
   Web of Science ®Google Scholar
• Hummers LK , DugowsonCE, DechowFJet al. A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon. Ann. Rheum. Dis.72(12), 1962–1967 (2012).
   PubMed Web of Science ®Google Scholar
• Schairer DO , ChouakeJS, NosanchukJD, FriedmanAJ. The potential of nitric oxide releasing therapies as antimicrobial agents. Virulence3(3), 271–279 (2012).
   PubMed Web of Science ®Google Scholar
• Jones ML , GanopolskyJG, LabbeA, WahlC, PrakashS. Antimicrobial properties of nitric oxide and its application in antimicrobial formulations and medical devices. Appl. Microbiol. Biotechnol.88(2), 401–407 (2010).
   PubMed Web of Science ®Google Scholar
• Maclean A , WeiXQ, HuangFP, Al-AlemUA, ChanWL, LiewFY. Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses. J. Gen. Virol.79(Pt 4), 825–830 (1998).
   PubMedGoogle Scholar
• Macmicking JD , NathanC, HomGet al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell81(4), 641–650 (1995).
   PubMed Web of Science ®Google Scholar
• Privett BJ , BroadnaxAD, BaumanSJ, RiccioDA, SchoenfischMH. Examination of bacterial resistance to exogenous nitric oxide. Nitric Oxide26(3), 169–173 (2012).
   PubMed Web of Science ®Google Scholar
• Englander L , FriedmanA. Nitric oxide nanoparticle technology: a novel antimicrobial agent in the context of current treatment of skin and soft tissue infection. J. Clin. Aesthet. Dermatol.3(6), 45–50 (2010).
   PubMedGoogle Scholar
• Ray GT , SuayaJA, BaxterR. Microbiology of skin and soft tissue infections in the age of community-acquired methicillin-resistant Staphylococcus aureus. Diagn. Microbiol. Infect. Dis.76(1), 24–30 (2013).
   PubMed Web of Science ®Google Scholar
• Ray GT , SuayaJA, BaxterR. Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. Population: a retrospective population-based study. BMC Infect. Dis.13(1), 252 (2013).
   PubMedGoogle Scholar
• Boucher HW , TalbotGH, BradleyJSet al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis.48(1), 1–12 (2009).
   PubMed Web of Science ®Google Scholar
• Major TA , PanmaneeW, MortensenJE, GrayLD, HoglenN, HassettDJ. Sodium nitrite-mediated killing of the major cystic fibrosis pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia under anaerobic planktonic and biofilm conditions. Antimicrob. Agents Chemother.54(11), 4671–4677 (2010).
   PubMed Web of Science ®Google Scholar
• Weller R , PriceRJ, OrmerodAD, BenjaminN, LeifertC. Antimicrobial effect of acidified nitrite on dermatophyte fungi, Candida and bacterial skin pathogens. J. Appl. Microbiol.90(4), 648–652 (2001).
   PubMed Web of Science ®Google Scholar
• Chen C , ShiYQ, SongJ, QiQS, GuL, WangPG. Delivery of nitric oxide released from beta-Gal-NONOate activation by beta-galactosidase and its activity against Escherichia coli. Biol. Pharm. Bull.29(6), 1239–1241 (2006).
   PubMed Web of Science ®Google Scholar
• Mcelhaney-Feser GE , RaulliRE, CihlarRL. Synergy of nitric oxide and azoles against Candida species in vitro. Antimicrob. Agents Chemother.42(9), 2342–2346 (1998).
   PubMed Web of Science ®Google Scholar
• Carpenter AW , SlombergDL, RaoKS, SchoenfischMH. Influence of scaffold size on bactericidal activity of nitric oxide-releasing silica nanoparticles. ACS Nano5(9), 7235–7244 (2011).
   PubMed Web of Science ®Google Scholar
• Hetrick EM , ShinJH, PaulHS, SchoenfischMH. Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials30(14), 2782–2789 (2009).
   PubMed Web of Science ®Google Scholar
• Ghaffari A , NeilDH, ArdakaniA, RoadJ, GhaharyA, MillerCC. A direct nitric oxide gas delivery system for bacterial and mammalian cell cultures. Nitric Oxide12(3), 129–140 (2005).
   PubMed Web of Science ®Google Scholar
• Ghaffari A , MillerCC, McMullinB, GhaharyA. Potential application of gaseous nitric oxide as a topical antimicrobial agent. Nitric Oxide14(1), 21–29 (2006).
   PubMed Web of Science ®Google Scholar
• Miller C , McmullinB, GhaffariAet al. Gaseous nitric oxide bactericidal activity retained during intermittent high-dose short duration exposure. Nitric Oxide20(1), 16–23 (2009).
   PubMed Web of Science ®Google Scholar
• Ghaffari A , JaliliR, GhaffariM, MillerC, GhaharyA. Efficacy of gaseous nitric oxide in the treatment of skin and soft tissue infections. Wound Repair Regen.15(3), 368–377 (2007).
   PubMed Web of Science ®Google Scholar
• Jones ML , GanopolskyJG, LabbeA, PrakashS. A novel nitric oxide producing probiotic patch and its antimicrobial efficacy: preparation and in vitro analysis. Appl. Microbiol. Biotechnol.87(2), 509–516 (2010).
   PubMed Web of Science ®Google Scholar
• Jones M , GanopolskyJG, LabbeAet al. Novel nitric oxide producing probiotic wound healing patch: preparation and in vivo analysis in a New Zealand white rabbit model of ischaemic and infected wounds. Int. Wound J.9(3), 330–343 (2012).
   PubMed Web of Science ®Google Scholar
• Cariello AJ , BispoPJ, De SouzaGF, PignatariAC, De OliveiraMG, Hofling-LimaAL. Bactericidal effect of S-nitrosothiols against clinical isolates from keratitis. Clin. Ophthalmol.6, 1907–1914 (2012).
   PubMedGoogle Scholar
• De Souza GF , Yokoyama-YasunakaJK, SeabraAB, MiguelDC, De OliveiraMG, UlianaSR. Leishmanicidal activity of primary S-nitrosothiols against Leishmania major and Leishmania amazonensis: implications for the treatment of cutaneous leishmaniasis. Nitric Oxide15(3), 209–216 (2006).
   PubMed Web of Science ®Google Scholar
• Lopez-Jaramillo P , RuanoC, RiveraJet al. Treatment of cutaneous leishmaniasis with nitric-oxide donor. Lancet351(9110), 1176–1177 (1998).
   PubMed Web of Science ®Google Scholar
• Fox S , WilkinsonTS, WheatleyPSet al. NO-loaded Zn(2+)-exchanged zeolite materials: a potential bifunctional anti-bacterial strategy. Acta Biomater.6(4), 1515–1521 (2010).
   PubMed Web of Science ®Google Scholar
• Narin G , AlbayrakCB, UlkuS. Antibacterial and bactericidal activity of nitric oxide-releasing natural zeolite. Appl. Clay Sci.50(4), 560–568 (2010).
   Web of Science ®Google Scholar
• Friedman A , BlecherK, SanchezDet al. Susceptibility of Gram-positive and -negative bacteria to novel nitric oxide-releasing nanoparticle technology. Virulence2(3), 217–221 (2011).
   PubMed Web of Science ®Google Scholar
• Martinez LR , HanG, ChackoMet al. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. J. Invest. Dermatol.129(10), 2463–2469 (2009).
   PubMed Web of Science ®Google Scholar
• Mihu MR , SandkovskyU, HanG, FriedmanJM, NosanchukJD, MartinezLR. The use of nitric oxide releasing nanoparticles as a treatment against Acinetobacter baumannii in wound infections. Virulence1(2), 62–67 (2010).
   PubMed Web of Science ®Google Scholar
• Macherla C , SanchezDA, AhmadiMSet al. Nitric oxide releasing nanoparticles for treatment of Candida albicans burn infections. Front. Microbiol.3, 1–9 (2012).
   PubMed Web of Science ®Google Scholar
• Han G , MartinezLR, MihuMR, FriedmanAJ, FriedmanJM, NosanchukJD. Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection. PLoS ONE4(11), e7804 (2009).
   PubMed Web of Science ®Google Scholar
• Schairer D , MartinezLR, BlecherKet al. Nitric oxide nanoparticles: pre-clinical utility as a therapeutic for intramuscular abscesses. Virulence3(1), 62–67 (2012).
   PubMed Web of Science ®Google Scholar
• Friedman AJ , BlecherK, SchairerDet al. Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione. Nitric Oxide25(4), 381–386 (2011).
   PubMed Web of Science ®Google Scholar
• Chouake J , SchairerD, KutnerAet al. Nitrosoglutathione generating nitric oxide nanoparticles as an improved strategy for combating Pseudomonas aeruginosa-infected wounds. J. Drugs Dermatol.11(12), 1471–1477 (2012).
   PubMed Web of Science ®Google Scholar
• Weller R . Nitric oxide: a key mediator in cutaneous physiology. Clin. Exp. Dermatol.28(5), 511–514 (2003).
   PubMed Web of Science ®Google Scholar
• Weller R , SchwentkerA, BilliarTR, VodovotzY. Autologous nitric oxide protects mouse and human keratinocytes from ultraviolet B radiation-induced apoptosis. Am. J. Physiol. Cell Physiol.284(5), C1140–C1148 (2003).
   PubMed Web of Science ®Google Scholar
• Sasaki M , HorikoshiT, UchiwaH, MiyachiY. Up-regulation of tyrosinase gene by nitric oxide in human melanocytes. Pigment Cell Res.13(4), 248–252 (2000).
   PubMedGoogle Scholar
• Feelisch M , Kolb-BachofenV, LiuDet al. Is sunlight good for our heart? Eur. Heart J. 31(9), 1041–1045 (2010).
   PubMed Web of Science ®Google Scholar
• Chen L , HuJY, WangSQ. The role of antioxidants in photoprotection: a critical review. J. Am. Acad. Dermatol.67(5), 1013–1024 (2012).
   PubMed Web of Science ®Google Scholar
• Seabra AB . Nitric oxide-releasing nanomaterials and skin care. In: Nanocosmetics and Nanomedicines. BeckR, GuterresS, PohlmannA ( Eds). Springer, NY, USA, 253–268 (2011).
   Google Scholar
• Han J , ColditzGA, HunterDJ. Risk factors for skin cancers: a nested case–control study within the Nurses’ Health Study. Int. J. Epidemiol.35(6), 1514–1521 (2006).
   PubMed Web of Science ®Google Scholar
• Wink DA , MirandaKM, EspeyMGet al. Mechanisms of the antioxidant effects of nitric oxide. Antioxid. Redox. Signal.3(2), 203–213 (2001).
   PubMed Web of Science ®Google Scholar
• Jariashvili K , MadhanB, BrodskyB, KuchavaA, NamicheishviliL, MetreveliN. UV damage of collagen: insights from model collagen peptides. Biopolymers97(3), 189–198 (2012).
   PubMed Web of Science ®Google Scholar
• Guy GP , BerkowitzZ, WatsonM, HolmanDM, RichardsonLC. Indoor tanning among young non-hispanic white females. JAMA Intern. Med.173(20), 1920–1922 (2013).
   PubMed Web of Science ®Google Scholar